.
MergerLinks Header Logo

Announced

China SXT to acquire a 70% stake in Jiangsu Renji Pharmaceutical.

Financials

Edit Data
Transaction Value-
Consideration TypeOrdinary Shares, Cash
Capital Owned-
Capital Bid For70%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Pharmaceuticals

Acquisition

Domestic

pharmaceuticals

Single Bidder

Friendly

Private

Majority

Pending

China

Synopsis

Edit

China SXT Pharmaceuticals, an innovative pharmaceutical company, agreed to acquire a 70% stake in Jiangsu Renji Pharmaceutical Chain, a pharmaceuticals company. Financial terms were not disclosed. "Renji Chain is a pharmaceutical retail chain with national online drug sales license and also the biggest retail chain integrating pharmaceutical marketing and service in Taizhou. Its market share has ranked first in the pharmaceutical retail industry in Taizhou for five consecutive years," Feng Zhou, China SXT Chief Executive Officer and Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US